In conclusion, the expression and function of IFI35 were investigated in patient specimens, cellular models, and animal models in order to understand the pathogenesis of RCC, and knockdown of IFI35 was investigated as a therapeutic approach to treat renal cancer. This evidence concerns the gene IFI35 and renal cell carcinoma.